These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 34243072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer.
    Sanz-Villafruela J, Bermejo-Casadesús C, Riesco-Llach G, Iglesias M, Martínez-Alonso M, Planas M, Feliu L, Espino G, Massaguer A.
    Inorg Chem; 2024 Oct 14; 63(41):19140-19155. PubMed ID: 39361042
    [Abstract] [Full Text] [Related]

  • 8. Benzothiazole-decorated iridium-based nanophotosensitizers for photodynamic therapy of cancer cells.
    Wang X, Song K, Deng Y, Liu J, Peng Q, Lao X, Xu J, Wang D, Shi T, Li Y, Deng D, Miao Y.
    Dalton Trans; 2022 Mar 01; 51(9):3666-3675. PubMed ID: 35165680
    [Abstract] [Full Text] [Related]

  • 9. Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy.
    Zhang P, Huang H, Banerjee S, Clarkson GJ, Ge C, Imberti C, Sadler PJ.
    Angew Chem Int Ed Engl; 2019 Feb 18; 58(8):2350-2354. PubMed ID: 30552796
    [Abstract] [Full Text] [Related]

  • 10. Chiral Iridium-Based TLD-1433 Analogues: Exploration of Enantiomer-Dependent Behavior in Photodynamic Cancer Therapy.
    Wang W, Wang L, Zhang Y, Shi Y, Zhang R, Chen L, Shi Z, Yuan S, Li X, He C, Li X.
    Inorg Chem; 2024 Apr 29; 63(17):7792-7798. PubMed ID: 38619892
    [Abstract] [Full Text] [Related]

  • 11. A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia.
    Lv W, Zhang Z, Zhang KY, Yang H, Liu S, Xu A, Guo S, Zhao Q, Huang W.
    Angew Chem Int Ed Engl; 2016 Aug 16; 55(34):9947-51. PubMed ID: 27381490
    [Abstract] [Full Text] [Related]

  • 12. Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor.
    Liu S, Chen H, Wu Q, Sun Y, Pei Y, Wang Z, Zhu D, Li G, Bryce MR, Chang Y.
    Inorg Chem; 2024 Sep 02; 63(35):16404-16417. PubMed ID: 39150967
    [Abstract] [Full Text] [Related]

  • 13. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
    Sanz-Villafruela J, Bermejo-Casadesús C, Martínez-Alonso M, Moro A, Lima JC, Massaguer A, Espino G.
    Dalton Trans; 2024 Jul 09; 53(27):11393-11409. PubMed ID: 38899369
    [Abstract] [Full Text] [Related]

  • 14. Tuning the organelle specificity and cytotoxicity of iridium(III) photosensitisers for enhanced phototheranostic applications.
    Zhu JH, Xu GX, Shum J, Lee LC, Lo KK.
    Chem Commun (Camb); 2021 Nov 11; 57(90):12008-12011. PubMed ID: 34709253
    [Abstract] [Full Text] [Related]

  • 15. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.
    Ma W, Guo L, Tian Z, Zhang S, He X, Li J, Yang Y, Liu Z.
    Dalton Trans; 2019 Apr 09; 48(15):4788-4793. PubMed ID: 30892340
    [Abstract] [Full Text] [Related]

  • 16. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
    Bevernaegie R, Marcélis L, Laramée-Milette B, De Winter J, Robeyns K, Gerbaux P, Hanan GS, Elias B.
    Inorg Chem; 2018 Feb 05; 57(3):1356-1367. PubMed ID: 29336560
    [Abstract] [Full Text] [Related]

  • 17. A Carbonic Anhydrase IX (CAIX)-Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti-Tumor Immunity.
    Su X, Wang WJ, Cao Q, Zhang H, Liu B, Ling Y, Zhou X, Mao ZW.
    Angew Chem Int Ed Engl; 2022 Feb 14; 61(8):e202115800. PubMed ID: 34842317
    [Abstract] [Full Text] [Related]

  • 18. An NIR Type I Photosensitizer Based on a Cyclometalated Ir(III)-Rhodamine Complex for a Photodynamic Antibacterial Effect toward Both Gram-Positive and Gram-Negative Bacteria.
    Liu C, Ding Q, Liu Y, Wang Z, Xu Y, Lu Q, Chen X, Liu J, Sun Y, Li R, Yang Y, Sun Y, Li S, Wang P, Kim JS.
    Inorg Chem; 2024 Jul 15; 63(28):13059-13067. PubMed ID: 38937959
    [Abstract] [Full Text] [Related]

  • 19. Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy.
    Tan Z, Lin M, Liu J, Wu H, Chao H.
    Dalton Trans; 2024 Aug 06; 53(31):12917-12926. PubMed ID: 39028267
    [Abstract] [Full Text] [Related]

  • 20. Ir(III) and Ru(II) Complexes in Photoredox Catalysis and Photodynamic Therapy: A New Paradigm towards Anticancer Applications.
    Raza MK, Noor A, Samantaray PK.
    Chembiochem; 2021 Dec 02; 22(23):3270-3272. PubMed ID: 34558773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.